Reversibility of Rocuronium-induced Profound Neuromuscular Blockade with Sugammadex in pediatric patient.
Not Applicable
- Conditions
- Surgical pediatric patients requiring general anesthesia.
- Registration Number
- JPRN-UMIN000013207
- Lead Sponsor
- Tokyo Metropolitan Children's Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients had or suspected neuromuscular disorders. 2)Patients had a hstory of allergy to any medication used during anesthesia. 3) Patients had a history of malignant hyperthermia. 4)Patients had significant hepatic and renal disfunction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The duration of the recovery to a TOF ratio of 0.9 and 90% of control in T1 after sugammadex was administered.
- Secondary Outcome Measures
Name Time Method